My research interests are developing mass spectrometry-based proteomics applications for studying human diseases such as malaria and cancers. Malaria remains one of the most lethal infectious diseases around the world and is caused by the Apicomplexan parasite Plasmodium falciparum. The life cycle of the parasite is complex and composed of several developmental stages in mosquito and human hosts. Throughout out my professional career I have used state-of-the art proteomic technologies to identify targets for intervention strategies at different stages of the parasite life cycle since the P falciparum genome was sequenced and was the first in publishing global proteomes of the human malaria parasite at various life cycle stages.  Since then I have been studying the biology of the parasite P. falciparum in human host for the development of novel intervention strategies using a variety of methods including expression profiling, post-translational modification (PTM) studies and protein-protein interaction network analyses.